Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic malignant syndrome.

T J Ingall, C Tennant

    The Medical Journal of Australia
    |November 3, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Neuroleptic Malignant Syndrome (NMS) is a rare, life-threatening condition caused by antipsychotic drugs. Early recognition and treatment are crucial for reducing mortality and long-term complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Production of Highly Polarized Positrons Using Polarized Electrons at MeV Energies.

    Physical review letters·2016
    Same author

    Transmission of megawatt relativistic electron beams through millimeter apertures.

    Physical review letters·2013
    Same author

    A controlled trial investigating the effect of music therapy during an acute psychotic episode.

    Acta psychiatrica Scandinavica·2011
    Same author

    Prospective study of early bereavement on psychological and behavioural cardiac risk factors.

    Internal medicine journal·2009
    Same author

    The association of depression with platelet activation: evidence for a treatment effect.

    Journal of thrombosis and haemostasis : JTH·2009
    Same author

    Thunderclap headache associated with reversible vasospasm and posterior leukoencephalopathy syndrome.

    Cephalalgia : an international journal of headache·2004

    Area of Science:

    • Neurology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Neuroleptic Malignant Syndrome (NMS) is a rare but potentially fatal complication of antipsychotic medications, with mortality rates up to 20%.
    • NMS presents with hyperpyrexia, muscular rigidity, altered consciousness, and autonomic dysfunction.
    • The underlying pathophysiology is believed to involve dopamine receptor blockade.

    Purpose of the Study:

    • To summarize the key features, pathophysiology, and management strategies for Neuroleptic Malignant Syndrome.
    • To highlight the importance of early recognition and treatment in mitigating NMS outcomes.

    Main Methods:

    • Review of existing literature on Neuroleptic Malignant Syndrome.
    • Analysis of clinical manifestations, proposed pathophysiology, and current treatment approaches.

    Related Experiment Videos

  • Discussion of specific drugs used in NMS management, including anticholinergics, L-dopa, bromocriptine, amantadine, and dantrolene sodium.

    • Main Results:

    • NMS is characterized by a distinct clinical tetrad: hyperpyrexia, severe muscle rigidity, autonomic instability, and altered mental status.
    • Dopamine receptor blockade is the hypothesized mechanism.
    • Current management involves antipsychotic drug cessation, supportive care, and pharmacologic interventions, though empirical evidence for specific treatments is limited.

    Conclusions:

    • Prompt diagnosis and intervention, including drug withdrawal and supportive care, are essential for improving patient outcomes in NMS.
    • While specific treatments lack robust empirical validation, early management may reduce mortality and long-term morbidity associated with NMS.
    • Further research is needed to establish evidence-based guidelines for NMS treatment.